| scholarly article | Q13442814 |
| P50 | author | Myron M. Levine | Q29564379 |
| Marcela F. Pasetti | Q56380831 | ||
| P2093 | author name string | Tao Wu | |
| Eileen M Barry | |||
| Avital Shimanovich | |||
| BreOnna C DeLaine | |||
| Christen L Grassel | |||
| P2860 | cites work | Outbreaks of multidrug-resistant Shigella sonnei gastroenteritis associated with day care centers--Kansas, Kentucky, and Missouri, 2005 | Q79189969 |
| Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media | Q81445405 | ||
| One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products | Q27860842 | ||
| Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). | Q30278967 | ||
| Quantitative PCR for detection of Shigella improves ascertainment of Shigella burden in children with moderate-to-severe diarrhea in low-income countries | Q30416070 | ||
| Prolonged episodes of acute diarrhea reduce growth and increase risk of persistent diarrhea in children | Q30430450 | ||
| Virulent Shigella flexneri causes damage to mitochondria and triggers necrosis in infected human monocyte-derived macrophages | Q33556806 | ||
| Mortality due to shigellosis: community and hospital data | Q33579264 | ||
| Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. | Q33613340 | ||
| Global burden of Shigella infections: implications for vaccine development and implementation of control strategies | Q33749510 | ||
| Strategy for cross-protection among Shigella flexneri serotypes | Q34000330 | ||
| Predominance of serotype-specific mucosal antibody response in Shigella flexneri-infected humans living in an area of endemicity | Q34008763 | ||
| Shigella isolates from the global enteric multicenter study inform vaccine development | Q34202171 | ||
| Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study | Q34345075 | ||
| Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine | Q34545910 | ||
| Global etiology of travelers' diarrhea: systematic review from 1973 to the present. | Q34606236 | ||
| Shigella type III secretion protein MxiI is recognized by Naip2 to induce Nlrc4 inflammasome activation independently of Pkcδ. | Q35091245 | ||
| Engineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine | Q35510455 | ||
| Human monocyte-derived macrophages infected with virulent Shigella flexneri in vitro undergo a rapid cytolytic event similar to oncosis but not apoptosis | Q35545918 | ||
| Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit | Q35598035 | ||
| Shigella flexneri infection: pathogenesis and vaccine development. | Q35671854 | ||
| Decreasing Shigellosis-related Deaths withoutShigellaspp.–specific Interventions, Asia | Q35804868 | ||
| Shigella IpaB and IpaD displayed on L. lactis bacterium-like particles induce protective immunity in adult and infant mice. | Q35946462 | ||
| The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study | Q36412034 | ||
| Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road | Q36844719 | ||
| Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a. | Q36920244 | ||
| Progress and pitfalls in Shigella vaccine research | Q37105553 | ||
| Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine. | Q37335984 | ||
| Effect of wild-type Shigella species and attenuated Shigella vaccine candidates on small intestinal barrier function, antigen trafficking, and cytokine release | Q37458618 | ||
| Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes | Q37720658 | ||
| Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208. | Q39146446 | ||
| Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile | Q39252440 | ||
| Shigella flexneri IpaH(7.8) facilitates escape of virulent bacteria from the endocytic vacuoles of mouse and human macrophages | Q39516481 | ||
| Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis | Q40211202 | ||
| Shigella flexneri induces apoptosis in infected macrophages | Q41614246 | ||
| Macrophage apoptosis in microbial infections. | Q41757390 | ||
| Outbreaks of acute gastroenteritis transmitted by person-to-person contact--United States, 2009-2010. | Q42282923 | ||
| Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection | Q44713046 | ||
| IL-8 is a key chemokine regulating neutrophil recruitment in a new mouse model of Shigella-induced colitis. | Q51189374 | ||
| Characterization of GRO alpha, beta and gamma expression in human colonic tumours: potential significance of cytokine involvement | Q67510954 | ||
| Protective efficacy of oral immunization with heat-killed Shigella flexneri 2a in animal model: study of cross protection, immune response and antigenic recognition | Q73507076 | ||
| Caspase-1 activation of IL-1beta and IL-18 are essential for Shigella flexneri-induced inflammation | Q73867640 | ||
| Invasive Shigella flexneri activates NF-kappa B through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells | Q73948765 | ||
| Experimental shigella keratoconjunctivitis; a preliminary report | Q78714396 | ||
| P433 | issue | 5 | |
| P921 | main subject | Shigella flexneri | Q1644417 |
| attenuated vaccine | Q1810913 | ||
| P577 | publication date | 2016-04-21 | |
| P1433 | published in | Pathogens and disease | Q27724629 |
| P1476 | title | Characterization of a multicomponent live, attenuated Shigella flexneri vaccine | |
| P478 | volume | 74 |
| Q47657350 | Editorial: Infection and immunity research at the University of Maryland, Baltimore |
| Q64270378 | Genome Analysis of Shigella flexneri Serotype 3b Strain SFL1520 Reveals Significant Horizontal Gene Acquisitions Including a Multidrug Resistance Cassette |
| Q37477191 | Shigella Vaccine Development: Finding the Path of Least Resistance |
Search more.